Works matching IS 00221899 AND DT 2023 AND VI 288
Results: 8
Variant-Specific Viral Kinetics in Acute COVID-19.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S136, doi. 10.1093/infdis/jiad314
- By:
- Publication type:
- Article
Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S83, doi. 10.1093/infdis/jiad300
- By:
- Publication type:
- Article
Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S117, doi. 10.1093/infdis/jiad287
- By:
- Publication type:
- Article
Long COVID After Bamlanivimab Treatment.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S126, doi. 10.1093/infdis/jiad286
- By:
- Publication type:
- Article
Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S101, doi. 10.1093/infdis/jiad285
- By:
- Publication type:
- Article
ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S77, doi. 10.1093/infdis/jiad246
- By:
- Publication type:
- Article
Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S92, doi. 10.1093/infdis/jiad209
- By:
- Publication type:
- Article
Immune Status and SARS-CoV-2 Viral Dynamics.
- Published in:
- Journal of Infectious Diseases, 2023, v. 288, p. S111, doi. 10.1093/infdis/jiad200
- By:
- Publication type:
- Article